Our Sienna Biotec API (Active Pharmaceutical Ingredients) program began in 2009 with a simple objective-facilitating the manufacture of complex API's, products for which complete vertical integration would help the business. We currently make APIs at 2 plants,including locations in Taiwan. Technical capability and dedicated sites to make complex API such as Pregabalin, Gabapentin, Ondansetron HCL and Lacosamide are an important feature of our API business.
Over time, we have been able to take this advantage to international markets, particularly to the SPAIN. Our number of APIs with regulated market approvals such as US and European drug master files (DMFs), our plants are ISO 14001 and ISO 9002 approved.
Sell
Our Sienna Biotec API (Active Pharmaceutical Ingredients) program began in 2009 with a simple objective-facilitating the manufacture of complex API's, products for which complete vertical integration would help the business. We currently make APIs at 2 plants,including locations in Taiwan. Technical capability and dedicated sites to make complex API such as Pregabalin, Gabapentin, Ondansetron HCL and Lacosamide are an important feature of our API business.